Short excerpt from a YouTube video (CIRS Ep) by Aaron Hartman, MD, featuring a conversational snippet where speakers discuss cirrhosis treatment options. The dialogue mentions a practitioner using MyCOVIND exclusively, contrasts that with cholestyramine (which may require prescribers able to write for it), and hypothesizes about provider type or comfort influencing treatment selection.
More from Aaron
Women’s Heart Attack Symptoms Differ From Men’s 95% of the Time — Only 30% Have Chest Pain #shorts
Heart Disease Kills More Women Than All Cancers Combined — 80% of Cardiac Research Is on Men #shorts
Women’s Physiology Was Systematically Ignored in Drug Research — The Consequences Are Still #shorts
Until 1993, Women Were Banned From Clinical Drug Trials — Then Those Drugs Were Prescribed t #shorts